Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice (original) (raw)
The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice
mehdi ghasemi
Epilepsy Research, 2008
View PDFchevron_right
Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat
Valerio Rizzo, Pierangelo Sardo
Neuroscience Letters, 2009
View PDFchevron_right
Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent
Colin Stott
Cannabis and Cannabinoid Research, 2019
View PDFchevron_right
Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB 1 agonist ACEA in the pentylenetetrazole-induced seizure in mice
mehdi ghasemi
Epilepsy Research, 2009
View PDFchevron_right
Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats
Marcio Augusto Moraes
Epilepsy Research, 2013
View PDFchevron_right
Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy
Chloe Larson
Epilepsy & Behavior, 2017
View PDFchevron_right
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
Ben Whalley
Neuroscience Letters, 2014
View PDFchevron_right
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice
zahra Mousavi
Iranian journal of pharmaceutical research : IJPR, 2015
View PDFchevron_right
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
Marcel Richard P
View PDFchevron_right
Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat
Fereshteh Motamedi
Neurochemical research, 2011
View PDFchevron_right
L-Type Calcium Channel Mediates Anticonvulsant Effect of Cannabinoids in Acute and Chronic Murine Models of Seizure
Leila Ahmad-Molaei
Neurochemical Research, 2012
View PDFchevron_right
Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2
ali ebrahimi
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015
View PDFchevron_right
Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor
Yoshihiro Urade
Scientific Reports, 2017
View PDFchevron_right
Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model
Aleksandra Wlaz
Journal of Neural Transmission, 2014
View PDFchevron_right
Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures
Misty Smith
Epilepsy Research
View PDFchevron_right
Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice
Jana Tchekalarova
Seizure-european Journal of Epilepsy, 2018
View PDFchevron_right
Possible mechanisms of action of cannabidiol in the epilepsies: a review
Gustavo Belotto
São Paulo Medical Journal, 2021
View PDFchevron_right
Endocannabinoids and their implications for epilepsy
Bradley Alger
Epilepsy currents / American Epilepsy Society
View PDFchevron_right
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
Cecilia Zavala-tecuapetla
International Journal of Molecular Sciences
View PDFchevron_right
Cannabidivarin is anticonvulsant in mouse and rat
Colin Stott
British Journal of Pharmacology, 2012
View PDFchevron_right
Cannabidiol targets a modulatory system for excitatory-inhibitory synaptic coordination, contributing to its anti-seizure action
Erica Nebet
View PDFchevron_right
Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy
Istvan Zolcseak
Biomedicines
View PDFchevron_right
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Daniel Friedman
Epilepsia, 2014
View PDFchevron_right
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats
Roberto Di Maio
Neurobiology of disease, 2014
View PDFchevron_right
Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy
Giuseppe Ferraro, Pierangelo Sardo, Valerio Rizzo
Epilepsy research, 2014
View PDFchevron_right
Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ9-Tetrahydrocannabinol
Amreen Jonas
Cannabis and Cannabinoid Research, 2020
View PDFchevron_right
Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures
Anna Borsodi
Epilepsy Research, 2012
View PDFchevron_right
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
Antonio Zuardi
Frontiers in pharmacology, 2017
View PDFchevron_right